We next sought to explore the driving forces causing this downregulation in LUAD and UCEC tumor samples, and identified multifaceted mechanisms in the DNA, RNA and protein levels contributing to INTU and IFT88 downregulation (Figures 3–7). The gene discussed is INTU; the disease is neoplasm.